SYT11 and Parkinson disease: In addition, mutations in ATP13A2 have been proposed to act by decreasing SYT11 (Synaptotagmin 11), another PD risk gene, through transcriptional and post-translational mechanisms, to induce lysosomal dysfunction and impaired degradation of autophagosomes.